HESA (Hashimoto’s Encephalopathy SREAT Alliance), the Anti-NMDA Receptor Encephalitis Foundation, Inc. (Canada), Encephalitis Global, and the Antibody-Negative Autoimmune Encephalitis Face Book group are proud to announce our upcoming educational symposium. It will be held on April 6, 2019 at Cornell University in New York, NY, titled: “Autoimmune Encephalitis: A Bridge Between Neurology and Psychiatry.”
Too many HE/AE patients have been misdiagnosed with psychotic disorders, or just misdiagnosed all together, wasting valuable treatment time. This very important symposium will be filmed and available on social media. The speakers are experts in the fields of neurology and psychiatry speaking to and educating medical professionals and offering a Q&A session.
Donations for this very important symposium are being taken at HESA’s Website. www.hesaonline.org. 100% of these donations will go directly to the expense of the symposium.
This video from Duke University talks about Autoimmune Encephalitis treatment and outcome. The information in this video can also apply to autoimmune encephalopathies, including therapies such as IVIG. It talks as well about treating symptoms such as seizures and neuropsychiatric symptoms.
Author and former New York Post writer, Susanah Cahalan, was diagnosed with anti-NMDA receptor encephalitis. This is an acute inflammation of the brain caused by autoimmunity. This diagnosis may also be considered in a differential diagnosis for HE/SREAT and can share symptoms, such as hallucinations and seizures. Ms. Cahalan’s vivid description of her hallucinations may ring with familiarity to patients diagnosed with HE/SREAT as well.
This video comes form Autoimmune Encephalitis Alliance from their Youtube.com channel, Autoimmune Encephalitis Alliance.
confusion and disorientation
concentration and memory problems
speech difficulties (usually transient)
muscle jerking (myoclonus)
impaired coordination and balance (ataxia)
seizures or seizure-like events
partial paralysis (transient)